PDLIM7 and nasopharyngeal carcinoma: It is therefore interesting to speculate that EBNA1 may modulate the ability of LMP1 to activate specific aspects of NF-κB signaling and that this in turn may impact upon the pathogenesis of NPC and other EBV-related tumours.